Multiparticulate extended-release composition of mesalamine
AssigneeRanbaxy Laboratories Limited
InventorsRajesh S. SHEAR, Abhishank SINGH, Girish MITTAL, Sumit MADAN, Vinod Kumar ARORA
Life of this patent
Estimating the term…
Abstract
The present invention relates to a multiparticulate extended-release pharmaceutical composition of mesalamine comprising a) an inert core, b) an active ingredient layer and one or more pharmaceutically acceptable excipients, c) an inner coating layer comprising a water-insoluble cellulose derivative, and d) an outer coating layer comprising an enteric polymer.
Claims11
A multiparticulate pharmaceutical composition of mesalamine comprising
- a) a multiparticulate extended-release pharmaceutical composition comprising a) an inert core, b) an active ingredient layer and one or more pharmaceutically acceptable excipients, c) an inner coating layer comprising a water-insoluble cellulose derivative, and d) an outer coating layer comprising an enteric polymer;
- and
- b) a multiparticulate immediate-release pharmaceutical composition comprising a) an inert core, b) an active ingredient layer and one or more pharmaceutically acceptable excipients, and c) an outer coating layer comprising an enteric polymer.
The pharmaceutical composition according to claim 9, wherein the ratio of multiparticulate extended-release composition to multiparticulate immediate-release composition is 85:15.
Dependencies are inferred from the claim text.